Who Just RaisedMalarVx, Inc.
Seattle, WA ยท Biotechnology
MalarVx, Inc. is a biotechnology company based in Seattle, Washington. In a Form D filed with the SEC on August 25, 2026, it reported raising $125,000 from 2 investors as part of an offering of up to $2,500,000. The first sale in the offering took place on August 8, 2026.
- Amount raised
- $125,000
- Offering size
- $2,500,000
- Investors so far
- 2
- Minimum investment
- $25,000
- First sale
- August 8, 2026
- Securities offered
- Other
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Seattle, Washington
- Incorporated
- Washington
- Entity type
- Corporation
- Revenue range
- $1,000,001 - $5,000,000
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $125,000 | $2,500,000 | 2 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Other health care raises in Washington
| Company | Location | Sector | Raised | Target | Filed |
|---|---|---|---|---|---|
| Q-Immune, Inc. | Seattle, WA | Health Care | $25K | $1M | |
| Seattle Neurosound Solutions, Inc. | Seattle, WA | Health Care | $100K | $5M | |
| Hexamer Therapeutics, Inc | Pullman, WA | Health Care | $500K | $2.5M | |
| DexCare, Inc. | Seattle, WA | Health Care | $12.9M | $22.7M | |
| Aptevo Therapeutics Inc. | Seattle, WA | Health Care | $3.5M | $3.5M | |
| Strella Biotechnology, Inc. | Seattle, WA | Health Care | $1.8M | $3.3M |